Verastem Inc has a consensus price target of $15.55 based on the ratings of 12 analysts. The high is $34 issued by Cantor Fitzgerald on July 6, 2023. The low is $5 issued by BTIG on October 5, 2022. The 3 most-recent analyst ratings were released by Jefferies, Mizuho, and Guggenheim on April 10, 2025, April 9, 2025, and March 24, 2025, respectively. With an average price target of $12.33 between Jefferies, Mizuho, and Guggenheim, there's an implied 64.44% upside for Verastem Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/10/2025 | Buy Now | 100% | Jefferies | Kelly Shi41% | → $15 | Initiates | → Buy | Get Alert |
04/09/2025 | Buy Now | 6.67% | Mizuho | Mara Goldstein57% | $9 → $8 | Maintains | Outperform | Get Alert |
03/24/2025 | Buy Now | 86.67% | Guggenheim | Michael Schmidt56% | $13 → $14 | Maintains | Buy | Get Alert |
03/24/2025 | Buy Now | 33.33% | HC Wainwright & Co. | Sean Lee68% | $7 → $10 | Maintains | Buy | Get Alert |
03/21/2025 | Buy Now | 86.67% | RBC Capital | Gregory Renza47% | $16 → $14 | Maintains | Outperform | Get Alert |
01/31/2025 | Buy Now | 20% | B. Riley Securities | Kalpit Patel41% | $7 → $9 | Maintains | Buy | Get Alert |
01/24/2025 | Buy Now | — | Guggenheim | Michael Schmidt56% | — | Reiterates | Buy → Buy | Get Alert |
01/07/2025 | Buy Now | 113.33% | RBC Capital | Gregory Renza47% | $13 → $16 | Maintains | Outperform | Get Alert |
12/19/2024 | Buy Now | 20% | Mizuho | Mara Goldstein57% | $7 → $9 | Maintains | Outperform | Get Alert |
12/19/2024 | Buy Now | -6.67% | HC Wainwright & Co. | Sean Lee68% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
10/18/2024 | Buy Now | 73.33% | RBC Capital | Gregory Renza47% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
10/18/2024 | Buy Now | — | Cantor Fitzgerald | Pete Stavropoulos42% | — | Reiterates | → Overweight | Get Alert |
10/18/2024 | Buy Now | -6.67% | HC Wainwright & Co. | Sean Lee68% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
09/30/2024 | Buy Now | 73.33% | Guggenheim | Michael Schmidt56% | → $13 | Initiates | → Buy | Get Alert |
08/13/2024 | Buy Now | 100% | Truist Securities | Srikripa Devarakonda44% | $18 → $15 | Maintains | Buy | Get Alert |
08/12/2024 | Buy Now | -6.67% | HC Wainwright & Co. | Sean Lee68% | $17.5 → $7 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | 73.33% | RBC Capital | Gregory Renza47% | $16 → $13 | Maintains | Outperform | Get Alert |
07/24/2024 | Buy Now | -6.67% | B. Riley Securities | Kalpit Patel41% | $21 → $7 | Maintains | Buy | Get Alert |
07/08/2024 | Buy Now | 140% | Truist Securities | Srikripa Devarakonda44% | $34 → $18 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | 166.67% | Alliance Global Partners | Jeff Grampp56% | $34 → $20 | Maintains | Buy | Get Alert |
05/28/2024 | Buy Now | 113.33% | RBC Capital | Gregory Renza47% | $32 → $16 | Maintains | Outperform | Get Alert |
05/28/2024 | Buy Now | 133.33% | HC Wainwright & Co. | Sean Lee68% | $17.5 → $17.5 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | Buy Now | 133.33% | HC Wainwright & Co. | Sean Lee68% | $17.5 → $17.5 | Reiterates | Buy → Buy | Get Alert |
03/19/2024 | Buy Now | 133.33% | HC Wainwright & Co. | Sean Lee68% | → $17.5 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | Buy Now | 326.67% | RBC Capital | Gregory Renza47% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
11/21/2023 | Buy Now | 260% | BTIG | Justin Zelin41% | → $27 | Assumes | → Buy | Get Alert |
11/15/2023 | Buy Now | 353.33% | Truist Securities | Srikripa Devarakonda44% | $39 → $34 | Maintains | Buy | Get Alert |
09/29/2023 | Buy Now | 180% | B. Riley Securities | Kalpit Patel41% | $21 → $21 | Reiterates | Buy → Buy | Get Alert |
09/27/2023 | Buy Now | 180% | B. Riley Securities | Kalpit Patel41% | → $21 | Initiates | → Buy | Get Alert |
08/29/2023 | Buy Now | 380% | Mizuho | Mara Goldstein57% | → $36 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | Buy Now | 326.67% | RBC Capital | Gregory Renza47% | $34 → $32 | Maintains | Outperform | Get Alert |
07/11/2023 | Buy Now | 420% | Truist Securities | Srikripa Devarakonda44% | $60 → $39 | Maintains | Buy | Get Alert |
07/06/2023 | Buy Now | 353.33% | Cantor Fitzgerald | Alethia Young76% | → $34 | Reiterates | Overweight → Overweight | Get Alert |
07/03/2023 | Buy Now | 353.33% | RBC Capital | Gregory Renza47% | $36 → $34 | Maintains | Outperform | Get Alert |
06/27/2023 | Buy Now | 700% | Truist Securities | Srikripa Devarakonda44% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | Buy Now | 700% | Truist Securities | Srikripa Devarakonda44% | → $60 | Reiterates | Buy → Buy | Get Alert |
06/15/2023 | Buy Now | 380% | Mizuho | Mara Goldstein57% | $24 → $36 | Upgrade | Neutral → Buy | Get Alert |
05/10/2023 | Buy Now | -73.33% | HC Wainwright & Co. | Sean Lee68% | $36 → $24 | Maintains | Buy | Get Alert |
03/30/2023 | Buy Now | -73.33% | Mizuho | Mara Goldstein57% | → $24 | Initiates | → Neutral | Get Alert |
03/15/2023 | Buy Now | -60% | RBC Capital | Gregory Renza47% | → $36 | Reiterates | → Outperform | Get Alert |
03/15/2023 | Buy Now | -60% | HC Wainwright & Co. | Sean Lee68% | → $36 | Reiterates | → Buy | Get Alert |
11/07/2022 | Buy Now | -60% | HC Wainwright & Co. | Sean Lee68% | $60 → $36 | Maintains | Buy | Get Alert |
10/05/2022 | Buy Now | -33.33% | BTIG | Robert Hazlett34% | $96 → $60 | Maintains | Buy | Get Alert |
The latest price target for Verastem (NASDAQ:VSTM) was reported by Jefferies on April 10, 2025. The analyst firm set a price target for $15.00 expecting VSTM to rise to within 12 months (a possible 100.00% upside). 23 analyst firms have reported ratings in the last year.
The latest analyst rating for Verastem (NASDAQ:VSTM) was provided by Jefferies, and Verastem initiated their buy rating.
The last upgrade for Verastem Inc happened on June 15, 2023 when Mizuho raised their price target to $36. Mizuho previously had a neutral for Verastem Inc.
There is no last downgrade for Verastem.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verastem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verastem was filed on April 10, 2025 so you should expect the next rating to be made available sometime around April 10, 2026.
While ratings are subjective and will change, the latest Verastem (VSTM) rating was a initiated with a price target of $0.00 to $15.00. The current price Verastem (VSTM) is trading at is $7.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.